Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Proportion measure

Year Type CMS eCQM ID Measure Name
2024 EH CMS819v2 Hospital Harm - Opioid-Related Adverse Events
2025 EH CMS816v4 Hospital Harm - Severe Hypoglycemia
2024 EH CMS816v3 Hospital Harm - Severe Hypoglycemia
2023 EH CMS816v2 Hospital Harm - Severe Hypoglycemia
2025 EC CMS771v6 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
2024 EC CMS771v5 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
2023 EC CMS771v4 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
2022 EC CMS771v3 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
2025 EC CMS646v5 Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer
2024 EC CMS646v4 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2023 EC CMS646v3 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2022 EC CMS646v2 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
2025 EC CMS645v8 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
2024 EC CMS645v7 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2023 EC CMS645v6 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2022 EC CMS645v5 Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
2025 EH CMS506v7 Safe Use of Opioids - Concurrent Prescribing
2024 EH CMS506v6 Safe Use of Opioids - Concurrent Prescribing
2023 EH CMS506v5 Safe Use of Opioids - Concurrent Prescribing
2022 EH CMS506v4 Safe Use of Opioids - Concurrent Prescribing